−10IDR
−13.66 BIDR
145.70 BIDR
250.00 M
About DIAGNOS LABORATORIUM UTAMA TBK
Sector
Industry
CEO
Mesha Rizal Sini
Website
Headquarters
Jakarta
Employees (FY)
64
Founded
2007
ISIN
ID1000158702
FIGI
BBG00YJ4QPJ2
PT Diagnos Laboratorium Utama Tbk engages in the provision of health support service. Its products include clinical pathology laboratory, anatomy pathology laboratory, and genomics laboratory. Its services include home care health tests, corporate health tests, and Covid-19 tests. The company was founded on August 29, 2007 and is headquartered in Jakarta, Indonesia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of DGNS is 322 IDR — it has decreased by 1.83% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on IDX exchange DIAGNOS LABORATORIUM UTAMA TBK stocks are traded under the ticker DGNS.
DGNS stock is 4.43% volatile and has beta coefficient of 0.01. Check out the list of the most volatile stocks — is DIAGNOS LABORATORIUM UTAMA TBK there?
Yes, you can track DIAGNOS LABORATORIUM UTAMA TBK financials in yearly and quarterly reports right on TradingView.
DGNS stock has risen by 3.87% compared to the previous week, the month change is a 6.40% fall, over the last year DIAGNOS LABORATORIUM UTAMA TBK has showed a 36.44% increase.
DGNS net income for the last quarter is −3.01 B IDR, while the quarter before that showed −2.91 B IDR of net income which accounts for −3.19% change. Track more DIAGNOS LABORATORIUM UTAMA TBK financial stats to get the full picture.
Today DIAGNOS LABORATORIUM UTAMA TBK has the market capitalization of 410.00 B, it has decreased by 1.88% over the last week.
Like other stocks, DGNS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DIAGNOS LABORATORIUM UTAMA TBK stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 23, 2024, the company has 64.00 employees. See our rating of the largest employees — is DIAGNOS LABORATORIUM UTAMA TBK on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DIAGNOS LABORATORIUM UTAMA TBK technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DIAGNOS LABORATORIUM UTAMA TBK stock shows the buy signal. See more of DIAGNOS LABORATORIUM UTAMA TBK technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DIAGNOS LABORATORIUM UTAMA TBK EBITDA is 599.93 M IDR, and current EBITDA margin is 0.41%. See more stats in DIAGNOS LABORATORIUM UTAMA TBK financial statements.